Epsilon M&A Deal Report - Biorhin

Transaction Multiples for the Valuation of Private Companies

Biolia > Biorhin

Announced Date : 18 October 2019

Type : Acquisition of Majority Stake

Deal Value : Yes

Acquirer : Biolia

Target: Biorhin

Target Country: France

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Founded in 1971, Biorhin SELARL owns and operates 15 medical laboratories in Alsace (Haut ...

No EMAT : 112558

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating ***

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1245

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
19/04/2023	Koninklijke DSM	Adare Pharmaceuticals (Adare Biome)	France	***
28/09/2020	Series A fund raising by Greycroft and Bullpen Capital	Sempiternal Aesthetics (SISU Aesthetic Clinic)	Ireland	*

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database